Drugmaker Eli Lilly and Co. said Friday that it will build a $3.5 billion manufacturing facility in Pennsylvania, as the company expands domestic production and capitalizes on surging sales of obesity ...
Eli Lilly (NYSE:LLY) announced a collaboration with Repertoire Immune Medicines to develop next generation autoimmune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results